Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, 100037, China
Location status: Recruiting
Location contact
Shumin Zhang
CONTACT
Xue Feng
CONTACT
NCT Number: NCT07660419
This single-center, randomized controlled trial aims to evaluate the efficacy of a mobile internet-based, home-based cardiac rehabilitation program in patients with mild to moderate coronary artery stenosis. A total of 176 eligible participants will be randomized to receive either a personalized lifestyle intervention via a mobile platform or routine clinical care. The primary endpoint is the change in non-calcified coronary plaque volume, as measured by coronary computed tomography angiography (CTA) at 12 months. Participants will be followed for a total of 36 months to comprehensively assess the long-term impact of this digital lifestyle intervention on plaque progression and cardiovascular outcomes.
Interested in participating?
Request Info18 year–70 year
All sexes
Interventional
Not applicable
Beijing, 100037, China
Location status: Recruiting
Shumin Zhang
CONTACT
Xue Feng
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
2.Age between 18 and 70 years. 3.Asymptomatic during exercise or recovery phases of cardiopulmonary assessment, including absence of angina, ST-segment depression, or complex arrhythmias at rest or during exercise.
4.Normal troponin levels. 5.Provided signed informed consent.
Exclusion criteria
3.Angina symptoms or signs during low-intensity exercise (<5 METs) or recovery. 4.Complex arrhythmias at rest or during exercise. 5.Hemodynamic abnormalities during exercise (e.g., failure of systolic blood pressure or heart rate to increase, or a decrease in blood pressure with increased exercise workload).
6.Severe psychological disorders. 7.Left ventricular ejection fraction (LVEF) < 40%. 8.Elevated troponin levels. 9.Inability to undergo cardiopulmonary exercise testing due to neuromuscular or musculoskeletal disorders.
10.Presence of other severe comorbidities. 11.Refusal to sign informed consent.
The intervention is a comprehensive, personalized cardiac rehabilitation program delivered via a mobile health (mHealth) platform. It consists of three core components: (1) Exercise Prescription: Personalized training plans aiming for 150 minutes of moderate-intensity aerobic exercise per week, combined with strength and flexibility training. (2) Nutritional Guidance: An initial offline nutritional assessment and personalized meal planning, followed by monthly online follow-ups and adjustments. (3) Psychological Support: Motivational interviewing and targeted psychological interventions provided as needed. Additionally, the program utilizes the mHealth platform to provide weekly online community supervision, progress tracking, and continuous health education to enhance patient compliance and engagement.
Time frame: Baseline and 12 months
The change in non-calcified plaque volume will be assessed and quantified using Coronary Computed Tomography Angiography (CCTA).
Contact information is provided by the study sponsor or research team.
Shumin Zhang
CONTACT
Xue Feng
CONTACT
China National Center for Cardiovascular Diseases
Other Gov
Effect of Mobile Internet Technology-Based Home Cardiac Rehabilitation on Coronary Artery Plaque in Patients With Mild to Moderate Stenosis
Acronym: MHCRT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07491107
Arterial Occlusive Diseases, Arteriosclerosis
Porto Alegre, Rio Grande do Sul, Brazil
View Trial DetailsNCT01435031
Arterial Occlusive Diseases, Arteriosclerosis
Santa Clara, California, United States
View Trial DetailsNCT07722637
Arterial Occlusive Diseases, Arteriosclerosis
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07363161
Arterial Occlusive Diseases, Arteriosclerosis
Homburg, Germany
View Trial Details